*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C9202 - Acute myeloblastic leukemia, in relapse - as a primary diagnosis code | C9202 - Acute myeloblastic leukemia, in relapse - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 12.87 | |
| Readmission Rate (%) | 46.56 | |
| Unplanned Readmission Rate (%) | 21.53 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 836: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,641 | ||||
| Total Hospitalizations with ICD C9202 - Acute myeloblastic leukemia, in relapse | 1,166 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C9202 - Acute myeloblastic leukemia, in relapse in DRG | 62.39 | ||||
| Avg LOS at DRG | 16.42 | ||||
| Avg LOS with ICD C9202 - Acute myeloblastic leukemia, in relapse | 17.65 | ||||
| Readmission Rate at DRG | 41.54 | ||||
| Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 44.16 | ||||
| Unplanned Readmission Rate at DRG | 17.96 | ||||
| Unplanned Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 21.06 | ||||
| Total Medicare payments at DRG | $591,889,384 | ||||
| Total Medicare payments with ICD C9202 - Acute myeloblastic leukemia, in relapse | $56,354,650 | ||||
| Total Medicare payment per Day at DRG | $2,852 | ||||
| Total Medicare payment per Day with ICD C9202 - Acute myeloblastic leukemia, in relapse | $2,739 | ||||
| Total Medicare payment per Hospitalization at DRG | $46,823 | ||||
| Total Medicare payment per Hospitalization with ICD C9202 - Acute myeloblastic leukemia, in relapse | $48,332 | ||||
| Total Medicare Charges at DRG | $2,437,161,576 | ||||
| Total Medicare Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $242,130,851 | ||||
| Avg Charges at DRG | $192,798 | ||||
| Avg Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $207,659 | ||||
| Mortality Rate at DRG | 21.77 | ||||
| Mortality Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 24.27 | ||||
| SNF Discharge Rate at DRG | 6.6 | ||||
| SNF Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 3.69 | ||||
| Home Discharge Rate at DRG | 30.51 | ||||
| Home Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 36.19 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 144 |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 60 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 52 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 18 |
| Dr. JILL R. GOULD | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 11 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 26 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 12 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,641 | ||||
| Total Hospitalizations with ICD C9202 - Acute myeloblastic leukemia, in relapse | 1,174 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C9202 - Acute myeloblastic leukemia, in relapse in DRG | 16.81 | ||||
| Avg LOS at DRG | 16.42 | ||||
| Avg LOS with ICD C9202 - Acute myeloblastic leukemia, in relapse | 17.67 | ||||
| Readmission Rate at DRG | 41.54 | ||||
| Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 44.09 | ||||
| Unplanned Readmission Rate at DRG | 17.96 | ||||
| Unplanned Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 21.03 | ||||
| Total Medicare payments at DRG | $591,889,384 | ||||
| Total Medicare payments with ICD C9202 - Acute myeloblastic leukemia, in relapse | $56,899,919 | ||||
| Total Medicare payment per Day at DRG | $2,852 | ||||
| Total Medicare payment per Day with ICD C9202 - Acute myeloblastic leukemia, in relapse | $2,742 | ||||
| Total Medicare payment per Hospitalization at DRG | $46,823 | ||||
| Total Medicare payment per Hospitalization with ICD C9202 - Acute myeloblastic leukemia, in relapse | $48,467 | ||||
| Total Medicare Charges at DRG | $2,437,161,576 | ||||
| Total Medicare Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $244,415,214 | ||||
| Avg Charges at DRG | $192,798 | ||||
| Avg Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $208,190 | ||||
| Mortality Rate at DRG | 21.77 | ||||
| Mortality Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 24.28 | ||||
| SNF Discharge Rate at DRG | 6.6 | ||||
| SNF Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 3.66 | ||||
| Home Discharge Rate at DRG | 30.51 | ||||
| Home Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 36.03 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,903 | ||||
| Total Hospitalizations with ICD C9202 - Acute myeloblastic leukemia, in relapse | 313 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C9202 - Acute myeloblastic leukemia, in relapse in DRG | 4.48 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD C9202 - Acute myeloblastic leukemia, in relapse | 10.42 | ||||
| Readmission Rate at DRG | 59.41 | ||||
| Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 56.07 | ||||
| Unplanned Readmission Rate at DRG | 21.51 | ||||
| Unplanned Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 21.31 | ||||
| Total Medicare payments at DRG | $84,826,538 | ||||
| Total Medicare payments with ICD C9202 - Acute myeloblastic leukemia, in relapse | $7,495,109 | ||||
| Total Medicare payment per Day at DRG | $2,856 | ||||
| Total Medicare payment per Day with ICD C9202 - Acute myeloblastic leukemia, in relapse | $2,297 | ||||
| Total Medicare payment per Hospitalization at DRG | $21,734 | ||||
| Total Medicare payment per Hospitalization with ICD C9202 - Acute myeloblastic leukemia, in relapse | $23,946 | ||||
| Total Medicare Charges at DRG | $328,471,815 | ||||
| Total Medicare Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $30,096,869 | ||||
| Avg Charges at DRG | $84,159 | ||||
| Avg Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $96,156 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 1.64 | ||||
| SNF Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 76.53 | ||||
| Home Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 78.27 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 836: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 138,345 | ||||
| Total Hospitalizations with ICD C9202 - Acute myeloblastic leukemia, in relapse | 121 | ||||
| DRG Share of Total Hospitalizations | 0.42 | ||||
| % of Total ICD C9202 - Acute myeloblastic leukemia, in relapse in DRG | 1.73 | ||||
| Avg LOS at DRG | 6.92 | ||||
| Avg LOS with ICD C9202 - Acute myeloblastic leukemia, in relapse | 9.71 | ||||
| Readmission Rate at DRG | 32.2 | ||||
| Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 46.74 | ||||
| Unplanned Readmission Rate at DRG | 22.95 | ||||
| Unplanned Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 18.48 | ||||
| Total Medicare payments at DRG | $1,845,581,658 | ||||
| Total Medicare payments with ICD C9202 - Acute myeloblastic leukemia, in relapse | $2,537,033 | ||||
| Total Medicare payment per Day at DRG | $1,929 | ||||
| Total Medicare payment per Day with ICD C9202 - Acute myeloblastic leukemia, in relapse | $2,159 | ||||
| Total Medicare payment per Hospitalization at DRG | $13,340 | ||||
| Total Medicare payment per Hospitalization with ICD C9202 - Acute myeloblastic leukemia, in relapse | $20,967 | ||||
| Total Medicare Charges at DRG | $9,021,459,592 | ||||
| Total Medicare Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $13,415,951 | ||||
| Avg Charges at DRG | $65,210 | ||||
| Avg Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $110,876 | ||||
| Mortality Rate at DRG | 5.29 | ||||
| Mortality Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 18.18 | ||||
| SNF Discharge Rate at DRG | 18.8 | ||||
| SNF Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 39.78 | ||||
| Home Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 41.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 867: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,149 | ||||
| Total Hospitalizations with ICD C9202 - Acute myeloblastic leukemia, in relapse | 71 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C9202 - Acute myeloblastic leukemia, in relapse in DRG | 1.02 | ||||
| Avg LOS at DRG | 10.0 | ||||
| Avg LOS with ICD C9202 - Acute myeloblastic leukemia, in relapse | 31.55 | ||||
| Readmission Rate at DRG | 32.03 | ||||
| Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 47.46 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 23.73 | ||||
| Total Medicare payments at DRG | $138,052,599 | ||||
| Total Medicare payments with ICD C9202 - Acute myeloblastic leukemia, in relapse | $4,152,952 | ||||
| Total Medicare payment per Day at DRG | $2,682 | ||||
| Total Medicare payment per Day with ICD C9202 - Acute myeloblastic leukemia, in relapse | $1,854 | ||||
| Total Medicare payment per Hospitalization at DRG | $26,812 | ||||
| Total Medicare payment per Hospitalization with ICD C9202 - Acute myeloblastic leukemia, in relapse | $58,492 | ||||
| Total Medicare Charges at DRG | $653,072,869 | ||||
| Total Medicare Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $26,473,904 | ||||
| Avg Charges at DRG | $126,835 | ||||
| Avg Charges with ICD C9202 - Acute myeloblastic leukemia, in relapse | $372,872 | ||||
| Mortality Rate at DRG | 5.59 | ||||
| Mortality Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 12.02 | ||||
| SNF Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 49.37 | ||||
| Home Discharge Rate with ICD C9202 - Acute myeloblastic leukemia, in relapse | 50.7 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 454 |
| UNIVERSITY OF WASHINGTON MEDICAL CENTER | 1959 NE PACIFIC ST | SEATTLE | WA | 98195 | 200 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 171 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 45 |
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 22 |
| Dr. COURTNEY DENTON DINARDO | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 20 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 66 |
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 38 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 35 |